Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiac Screening in Survivors of Hodgkin's Disease Treated With Mediastinal Irradiation

NCT00165425 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.

NCT NCT00165425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00165425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiac Screening in Survivors of Hodgkin's Disease Treated With Mediastinal Irradiation
Lead sponsor
Dana-Farber Cancer Institute
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 29, 2004
Completion date
December 31, 2028
Enrollment
210 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin's disease